Franklin Resources’s Sana Biotechnology SANA Stock Holding History

Franklin Resources’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-57,909	Closed	-$167K	–	3314
2026 Q1	$167K	Sell	57,909 -11,492	-17%	-$45.3K	﹤0.01%	2829
2025 Q4	$282K	Sell	69,401 -23,680	-25%	-$106K	﹤0.01%	2648
2025 Q3	$330K	Hold	93,081	–	–	﹤0.01%	2622
2025 Q2	$254K	Buy	93,081 +43,247	+87%	+$89.2K	﹤0.01%	2631
2025 Q1	$83.7K	Buy	49,834 +3,197	+7%	+$8.94K	﹤0.01%	2824
2024 Q4	$76K	Buy	46,637 +64	+0.1%	+$191	﹤0.01%	2772
2024 Q3	$187K	Buy	46,573 +161	+0.3%	+$846	﹤0.01%	2654
2024 Q2	$253K	Buy	46,412 +4,943	+12%	+$39.4K	﹤0.01%	2491
2024 Q1	$415K	Buy	41,469 +37	+0.1%	+$277	﹤0.01%	2338
2023 Q4	$169K	Buy	+41,432	New	+$153K	﹤0.01%	2385
2023 Q3	–	Sell	-44,112	Closed	-$263K	–	2768
2023 Q2	$263K	Buy	+44,112	New	+$254K	﹤0.01%	2272
2021 Q4	–	Sell	-14,032	Closed	-$316K	–	2541
2021 Q3	$316K	Buy	+14,032	New	+$295K	﹤0.01%	2068

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Franklin Resources's SANA Position: Q2 2026 in Review

Franklin Resources sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 57,909 shares — an estimated $167K sold.

Franklin Resources first reported a position in SANA in Q3 2021 and held it in 12 quarters. The position peaked at $415K in Q1 2024. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Franklin Resources reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
Franklin Resources sold 57,909 Sana Biotechnology shares in Q2 2026, an estimated $167K.
Franklin Resources first reported a position in Sana Biotechnology in Q3 2021 and held it in 12 quarters.
Franklin Resources's Sana Biotechnology position peaked at $415K in Q1 2024.
212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.